Actively Recruiting

Age: 18Years - 99Years
All Genders
NCT06785779

Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

Led by Novartis Pharmaceuticals · Updated on 2025-12-30

77

Participants Needed

4

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to assess the treatment satisfaction of HS patients newly started on secukinumab in Saudi Arabia, in terms of patient reported convenience, perceived safety, perceived effectiveness and global treatment satisfaction as measured by the treatment satisfaction questionnaire for medication (TSQM) at week 24 among moderate to severe HS patients.

CONDITIONS

Official Title

Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female adults 18 years of age or older at the time of data collection
  • Confirmed diagnosis of active moderate to severe Hidradenitis Suppurativa
  • Have not previously received secukinumab; first dose within one month of signing informed consent
  • May be using antibiotics or have undergone surgery as part of routine care
  • Agree to sign informed consent and complete questionnaires
Not Eligible

You will not qualify if you...

  • Not meeting all inclusion criteria
  • Refusal to participate or to sign informed consent
  • History of off-label use of biological treatments or JAK inhibitors

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Novartis Investigative Site

Riyadh, SAU, Saudi Arabia, 11525

Actively Recruiting

2

Novartis Investigative Site

Jeddah, Saudi Arabia, 21391

Actively Recruiting

3

Novartis Investigative Site

Jeddah, Saudi Arabia, 23311

Actively Recruiting

4

Novartis Investigative Site

Riyadh, Saudi Arabia, 11211

Actively Recruiting

Loading map...

Research Team

N

Novartis Pharmaceuticals

CONTACT

N

Novartis Pharmaceuticals

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here